Skip to main content
. 2012 Jun 13;2012(6):CD007543. doi: 10.1002/14651858.CD007543.pub2

Comparison 1. Type 1 diabetes: enhanced versus standard therapy.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Annualized risk difference (%) 3 1228 Annualized risk difference (%) (Fixed, 95% CI) ‐1.84 [‐2.56, ‐1.11]
2 Incidence of clinical neuropathy after 5 years: risk ratio 3 1228 Risk Ratio (M‐H, Fixed, 95% CI) 0.46 [0.33, 0.63]
3 Annual change in peroneal nerve motor conduction velocity 4 1371 Mean Difference (IV, Fixed, 95% CI) 0.61 [0.51, 0.71]
4 Annual change in median nerve motor conduction velocity 2 1241 Mean Difference (IV, Fixed, 95% CI) 0.46 [0.36, 0.57]
5 Annual change in ulnar nerve motor conduction velocity 2 134 Mean Difference (IV, Random, 95% CI) 1.49 [‐0.74, 3.71]
6 Annual change in vibration threshold in the feet 3 177 Std. Mean Difference (IV, Fixed, 95% CI) 0.32 [0.02, 0.62]